Blockade of nigral and pallidal opioid receptors suppresses vacuous chewing movements in a rodent model of tardive dyskinesia

Neuroscience

Volumn 112, Issue 4, 2002, Pages 851-859

  McCormick, S E ^a   Stoessl, A J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Dynorphin; Enkephalin; Globus pallidus; Opioid peptides; Substantia nigra pars reticulata

Indexed keywords

DELTA OPIATE RECEPTOR ANTAGONIST; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DYNORPHIN; FLUPHENAZINE; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTRINDOLE; NEUROLEPTIC AGENT; NORBINALTORPHIMINE; OPIATE ANTAGONIST; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG INFUSION; DRUG MECHANISM; DRUG SELECTIVITY; GLOBUS PALLIDUS; MALE; MASTICATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SUBSTANTIA NIGRA; TARDIVE DYSKINESIA;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYNORPHINS; DYSKINESIA, DRUG-INDUCED; FLUPHENAZINE; GLOBUS PALLIDUS; MALE; MASTICATION; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; SOMATOSTATIN; SUBSTANTIA NIGRA;

EID: 0037135274     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(02)00127-6     Document Type: Article

References (44)

1. Oral dyskinesias and striatal lesions in rats after long-term co-treatment with haloperidol and 3-nitropropionic acid
2. Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats
3. The rat model of tardive dyskinesia: Relationship between vacuous chewing movements and motor activity during acute and long-term haloperidol treatment
4. 5-enkephalin-like immunoreactivity in rats following chronic treatment with haloperidol but not with clozapine: Implications for the pathogenesis of neuroleptic-induced movement disorders
5. Decreased μ-opioid receptor binding in the globus pallidus of rats treated with chronic haloperidol
6. Striatal enlargement in rats chronically treated with neuroleptic
7. Haloperidol-induced vacuous chewing in rats: Suppression by α-methyl-tyrosine
8. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol
9. 2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias
10. Spontaneous orofacial movements in rodents induced by long-term neuroleptic administration: A second opinion
11. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
12. Quetiapine-related tardive dyskinesia
13. Intermittent versus continuous neuroleptic treatment in a rat model
14. Neurotransmitters and neuromodulators in the basal ganglia
15. Mixture of distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia
16. Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antipsychotic drugs
17. Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: Possible relation to parkinsonian symptoms
18. Tardive dyskinesia: Prevalence and risk factors
19. Neuroleptic-induced oral movements in rats: Methodological issues
20. On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus
21. Functional implications of kappa receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease
22. Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias
23. Correlation of vacuous chewing movements with morphological changes in rats following long-term haloperidol treatment
24. Morphological changes in met(5)-enkephalin-immunoreactive synaptic boutons in the rat neostriatum after haloperidol decanoate treatment
25. Prevalence of extrapyramidal syndromes in psychiatric inpatients and the relationship of clozapine to tardive dyskinesia
26. A κ opioid antagonist blocks sensitization in a rodent model of Parkinson's disease
27. Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for μ opioid receptors
28. Naloxone prevents and blocks the emergence of neuroleptic-mediated oral stereotypic behaviors
29. Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists
30. The selectivity of the opioid antagonist, naltrindole, for δ-opioid receptors
31. Pharmacological characterization of spontaneous or drug-associated purposeless chewing movements in rats
32. Discrete mapping of brain μ and δ opioid receptors using selective peptides: Quantitative autoradiograpy, species differences and comparison with κ receptors
33. Dynorphin regulates D1 dopamine receptor-mediated responses in the striatum: Relative contributions of pre- and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by altered immediate-early gene induction
34. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior
35. Effects of ethanol in a putative rodent model of tardive dyskinesia
36. 2 receptor antagonists
37. The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia
38. Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia in three rat strains
39. Increase in preproenkephalin mRNA and enkephalin content of rat striatum after daily injections of haloperidol for 2 to 3 weeks
40. Dose-related effects of continuous levodopa infusion in rats with unilateral lesions of the substantia nigra
41. Dopamine D(1A) receptor function in a rodent model of tardive dyskinesia
42. Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months neuroleptic treatment
43. Gender differences in tardive dyskinesia: A critical review of the literature